| Oakland Nursing & Rehabilitation Center | |
| 706 East Alder Street, Oakland, Maryland 21550 | |
| (301) 334-2319 | |
| Name | Oakland Nursing & Rehabilitation Center |
|---|---|
| Location | 706 East Alder Street, Oakland, Maryland |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 48.3% |
| Medicare ID (CCN) | 215232 |
| Legal Business Name | Oakland Health Care Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1447705595 |
| Organization Name | OAKLAND HEALTH CARE LLC |
| Doing Business As | OAKLAND NURSING AND REHABILITATION CENTER |
| Address | 706 E Alder St, Oakland, MD 21550 |
| Phone Number | 301-334-2319 |
News Archive
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.
Vanderbilt University announced Oct. 21 that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Associate Professor of Chemistry David Wright and Professor of Biomedical Engineering Rick Haselton, titled "Coffee Ring Stain Diagnostics for Malaria."
"Global health funding barely grew last year," according to a report released Wednesday by the Institute for Health Metrics and Evaluation, a research unit at the University of Washington in Seattle, Bloomberg reports.
› Verified 5 days ago
| NPI Number | 1568401883 |
| Organization Name | MID-ATLANTIC LONG TERM CARE OF WESTERN MARYLAND, LLC |
| Address | 706 E Alder St, Oakland, MD 21550 |
| Phone Number | 301-334-2319 |
News Archive
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.
Vanderbilt University announced Oct. 21 that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Associate Professor of Chemistry David Wright and Professor of Biomedical Engineering Rick Haselton, titled "Coffee Ring Stain Diagnostics for Malaria."
"Global health funding barely grew last year," according to a report released Wednesday by the Institute for Health Metrics and Evaluation, a research unit at the University of Washington in Seattle, Bloomberg reports.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.
Vanderbilt University announced Oct. 21 that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Associate Professor of Chemistry David Wright and Professor of Biomedical Engineering Rick Haselton, titled "Coffee Ring Stain Diagnostics for Malaria."
"Global health funding barely grew last year," according to a report released Wednesday by the Institute for Health Metrics and Evaluation, a research unit at the University of Washington in Seattle, Bloomberg reports.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.98 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.79 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 71.59 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.4 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.14 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.13 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 1.01 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.53 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.99 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.67 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 77.11 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.72 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 32.41 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 5.88 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.53 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 61 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.24 | 82.93 |
News Archive
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.
Vanderbilt University announced Oct. 21 that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Associate Professor of Chemistry David Wright and Professor of Biomedical Engineering Rick Haselton, titled "Coffee Ring Stain Diagnostics for Malaria."
"Global health funding barely grew last year," according to a report released Wednesday by the Institute for Health Metrics and Evaluation, a research unit at the University of Washington in Seattle, Bloomberg reports.
› Verified 5 days ago
Oakland Nursing & Rehabilitation Center Location: 706 East Alder Street, Oakland, Maryland 21550 Phone: (301) 334-2319 | |
Garrett County Subacute Unit Location: 251 North Fourth Street, Oakland, Maryland 21550 Phone: (301) 533-4220 |